Clinical Trial Update: Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study [Phase 4]

View source ↗

Summary

A multicenter Phase 4 study suggests that once-monthly darbepoetin alfa maintains hemoglobin concentration comparably to the every-2-weeks dosing schedule in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Chronic Kidney Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING